Catalog

Methimazole embryofetopathy

No MMS code

Link to WHO Definition

Methimazole embryofetopathy – http://id.who.int/icd/entity/1204409156

Methimazole embryofetopathy is a teratogenic disorder observed in a fetus or newborn when the mother has taken methimazole, an antithyroid agent, during pregnancy. Reported abnormalities include cerebral atrophy, oesophageal atresia and tracheooesophageal fistula, choanal atresia, and other birth defects.